🔎 Trials Near Me

Home › Mga Seizure › Texas

Pag-aaral pangklinika para sa Mga Seizure sa Texas

14 pag-aaral para sa Mga Seizure ang naghahanap ng mga kalahok sa mga site sa Texas.

Mga Lungsod sa Texas

Opisyal na teksto ng pag-aaral (English)

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

  • Child Neurology Consultants of Austin, Austin
Nagre-recruitPhase 3
Edad 2 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04462770

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

  • Children's Health Specialty Center, Dallas
  • UTHealth Houston, Houston
Nagre-recruitPhase 3
Edad 2 hanggang 55 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05066217

Prospective Natural History Study of POLG Disease

  • Baylor Hospital, Dallas
  • UTHealth Houston, Houston
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07775872

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

  • Baylor College of Medicine, Houston
  • University of Texas Health Science Center in Houston, Houston
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07594119

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

  • Neurology Consultants of Dallas, PA, Dallas
  • Tarrant Neurology Consultants, Fort Worth
  • UT Health San Antonio, San Antonio
  • at 1 pa
Nagre-recruitPhase 2/3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT06132893

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

  • Child Neurology & Consultants of Austin, Austin
  • ANESC Research, El Paso
Nagre-recruitPhase 1
Edad 12 hanggang 75 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07233239

Mapping of Human Cognition

  • The University of Texas Health Science Center at Houston, Houston
Nagre-recruit
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 14, 2026 · NCT05989893

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

  • UT Southwestern Medical Center, Dallas
  • UTHealth Houston, Houston
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 9, 2026 · NCT05135091

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  • Austin Epilepsy Care Center, Austin
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT05716100

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

  • Baylor College of Medicine, Houston
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ene 23, 2026 · NCT07219407

Pharmacological Modulation of Brain Oscillations in Memory Processing

  • University of Texas Southwestern Medical Center, Dallas
Nagre-recruitMaagang Phase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Okt 3, 2025 · NCT05594017

Pediatric Dose Optimization for Seizures in Emergency Medical Services

  • University of Texas Southwestern, Dallas
  • Baylor College of Medicine, Houston
Nagre-recruitPhase 3
6 Months – 13 Years · Lahat ng kasarian · Na-update Set 30, 2025 · NCT05121324

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

  • Praxis Research Site, Round Rock
  • Praxis Research Site, Seabrook
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Abr 3, 2025 · NCT06908356

Epilepsy Learning Healthcare System (ELHS)

  • UT Southwestern Children's Dallas, Dallas
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Ago 30, 2024 · NCT06265103

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.